ROM InWest Invests €1.5 million into AI and Computer Vision Company Kepler Vision Technologies

ROM InWest Invests

Kepler Vision Technologies, a software developer in the healthcare sector, has received an investment of €1.5 million from Dutch investment company ROM InWest. With the investment, the health-technology company will scale up the production of their Kepler Night Nurse. This smart sensor technology, applicable in elderly care among others, helps reduce the workload for healthcare professionals while simultaneously improving the quality of care.

Kepler Vision’s Night Nurse

Kepler Vision’s Night Nurse solution is a computer vision-based body language detection system. By combining AI and computer vision, Kepler Night Nurse is able to detect falls, patient discomfort and abnormal behaviour, notifying care staff so that they can respond immediately. The company has also recently added a new lying position detection feature that identifies the potential of pressure ulcers. This solution technology outperforms motion sensors, bed mats, and wearable monitoring systems by a factor of 1,000 in cutting down on false alarms, and the unnecessary strain they place on care staff.

International Distribution

The Night Nurse product has already been distributed internationally across 8 European countries through 26 different partners in care homes and hospitals. With the investment from ROM InWest, the company will look to widen its reach with plans of entering the UK and US market already in motion.

Harro Stokman, CEO of Kepler Vision Technologies says:

“The healthcare sector has been facing urgent staff shortages for years. This problem is only getting worse due to an aging population. A quarter of the current workforce will retire in the next five years, while the number of elderly people will continue to grow. Elderly care therefore needs more support than ever. Thanks to the investment from ROM InWest, we can scale up our Kepler Night Nurse production to help more healthcare professionals in their work. My goal is for our software to be accessible across the world, and with great support like this, we get closer to achieving this”.

Janet Nieboer, CEO of ROM InWest comments:

“We are proud to contribute to Kepler’s healthcare solution. The Kepler Night Nurse offers a smart and more reliable alternative to existing home automation systems. It contributes to good patient care and makes the work of healthcare professionals more efficient. Smart healthcare solutions like these are essential to maintain the quality and affordability of our healthcare.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.